The health insurance and benefits management firm reported adjusted diluted quarterly earnings per share (EPS) of $2.37 on revenues of $48.7 billion. He noted that it will affect coverage affordability.
Previously on 04/07/2017, Cantor Fitzgerald reported on UnitedHealth (NYSE:UNH) raised the target price from $0.00 to $200.00.
Shares rose 1.8% in premarket trading Tuesday as the company raised its annual revenue and profit outlooks. UnitedHealth Group had 28 analyst reports since September 2, 2015 according to SRatingsIntel.
Based on the latest notes released to investors, 15 analysts have issued a rating of "buy", 9 analysts "outperform", 0 analysts "hold", 0 analysts "underperform" and 1 analysts "sell". The consensus 12-month price target was $184.95 before results were announced. If you are accessing this piece on another domain, it was copied illegally and reposted in violation of USA & worldwide copyright laws. The Illinois-based Calamos Advsrs Limited Liability Company has invested 0.56% in UnitedHealth Group Inc (NYSE:UNH). Argus restated a buy rating and set a $170.00 target price on shares of UnitedHealth Group in a report on Monday, January 23rd. The day began at US$71.33 but the price moved to US$71.33 at one point during the trading and finally capitulating to a session high of US$72.33. UnitedHealth Group Incorporated (NYSE:UNH) shares have been recently spotted -3.11% away from the 52-week high, and 34.38% away from the 52-week low mark. Stockholders of record on Friday, March 10th were paid a $0.625 dividend. This represents a $2.50 dividend on an annualized basis and a yield of 1.52%. The ex-dividend date was Wednesday, March 8th.
Now the P/E of UnitedHealth Group Incorporated stands at 23.06. WILENSKY GAIL R sold $822,000 worth of stock or 5,460 shares. The stock was sold at an average price of $162.31, for a total transaction of $861,866.10. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
The number of shares now held by investors is 964.85 Million. Following the sale, the director now directly owns 35,941 shares of the company's stock, valued at approximately $6,141,957.49. The disclosure for this sale can be found here. The stock has risen 31 percent in the last 12 months.
Institutional investors have recently modified their holdings of the stock.
Shares of UnitedHealth Group (NYSE:UNH) opened at 167.18 on Tuesday. The forecast of 22 surveyed investment analysts covering the stock advises investors to Buy stake in the company. Eqis Mgmt has invested 0.09% in UnitedHealth Group Inc (NYSE:UNH). Beck Mack & Oliver LLC now owns 2,708 shares of the healthcare conglomerate's stock valued at $379,000 after buying an additional 8 shares during the period.
Unitedhealth Group reported a 9.4 percent revenue increase during its first quarter.
Murphy Oil Corporation (NYSE:MUR) ended its day at $27.93 with the rising stream of 1.34% and its total traded volume was 2.02 million shares less than the average volume. Surgical Care said it serves about 1 million patients a year at its 205 facilities. A lower P/B ratio could mean that the stock is undervalued.
A number of other hedge funds have also bought and sold shares of UNH.
UnitedHealth Group Inc. is doing well doing business with the USA government. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx.